|
🦁
|
Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis.
10 auth.
R. Admiraal,
C. van Kesteren,
C. M. Jol-van der Zijde,
A. Lankester,
M. Bierings,
T. Egberts,
...
M. V. van Tol,
C. Knibbe,
R. Bredius,
J. Boelens
|
7 |
2015 |
7
🦁
|
|
🦁
|
Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a multicentre, retrospective, pharmacodynamic cohort analysis.
14 auth.
R. Admiraal,
S. Nierkens,
M. D. de Witte,
E. Petersen,
Gerjan Fleurke,
Luka Verrest,
S. Belitser,
R. Bredius,
R. Raymakers,
C. Knibbe,
...
M. Minnema,
C. van Kesteren,
J. Kuball,
J. Boelens
|
7 |
2017 |
7
🦁
|
|
🦁
|
Excellent T-cell reconstitution and survival depend on low ATG exposure after pediatric cord blood transplantation.
7 auth.
R. Admiraal,
C. Lindemans,
C. van Kesteren,
M. Bierings,
A. Versluijs,
S. Nierkens,
...
J. Boelens
|
7 |
2016 |
7
🦁
|
|
🦁
|
Viral reactivations and associated outcomes in the context of immune reconstitution after pediatric hematopoietic cell transplantation
9 auth.
R. Admiraal,
C. D. de Koning,
C. Lindemans,
M. Bierings,
A. Wensing,
B. Versluys,
...
T. Wolfs,
S. Nierkens,
J. Boelens
|
6 |
2017 |
6
🦁
|
|
🦁
|
Population Pharmacokinetic Modeling of Thymoglobulin® in Children Receiving Allogeneic-Hematopoietic Cell Transplantation: Towards Improved Survival Through Individualized Dosing
8 auth.
R. Admiraal,
C. Kesteren,
C. M. Jol-van der Zijde,
M. Tol,
I. Bartelink,
R. Bredius,
...
J. Boelens,
C. Knibbe
|
6 |
2015 |
6
🦁
|
|
🐜
|
Impact of serotherapy on immune reconstitution and survival outcomes after stem cell transplantations in children: thymoglobulin versus alemtuzumab.
12 auth.
L. Willemsen,
C. M. Jol-van der Zijde,
R. Admiraal,
H. Putter,
A. Jansen-Hoogendijk,
Monique M. Ostaijen-ten Dam,
...
J. Wijnen,
C. van Kesteren,
Jacqueline L. m. Waaijer,
A. Lankester,
R. Bredius,
M. V. van Tol
|
6 |
2015 |
6
🐜
|
|
🦁
|
Towards evidence-based dosing regimens in children on the basis of population pharmacokinetic pharmacodynamic modelling
R. Admiraal,
C. van Kesteren,
J. Boelens,
R. Bredius,
D. Tibboel,
C. Knibbe
|
5 |
2013 |
5
🦁
|
|
🐜
|
Fludarabine exposure predicts outcome after CD19 CAR T-cell therapy in children and young adults with acute leukemia
21 auth.
L. Dekker,
F. Calkoen,
Yilin Jiang,
Hilly Blok,
S. Veldkamp,
C. D. de Koning,
Maike Spoon,
R. Admiraal,
P. Hoogerbrugge,
B. Vormoor,
...
J. Vormoor,
H. Visscher,
M. Bierings,
Marieke Van Der Vlugt,
H. van Tinteren,
A. L. Nijstad,
A. Huitema,
K. V. D. van der Elst,
R. Pieters,
C. Lindemans,
S. Nierkens
|
5 |
2022 |
5
🐜
|
|
🐬
|
Immune reconstitution and outcomes after conditioning with anti-thymocyte-globulin in unrelated cord blood transplantation; the good, the bad, and the ugly.
C. D. de Koning,
R. Admiraal,
S. Nierkens,
J. Boelens
|
5 |
2017 |
5
🐬
|
